A recent set of studies reports how blood–brain barrier leakage may affect inflammation in the brain, potentially leading to acceleration of neurological aging in mice.
At the 21st Spinal Research Annual Network Meeting, we had the pleasure of speaking with Aileen Anderson about her talk on ‘Traumatic CNS injury and the inflammatory stem cell niche’, including the obstacles involved with tissue regeneration following injury and the how this could be overcome.
A novel study has identified the inflammatory markers IL-1 and IL-6 as potential biomarkers for diagnosis, prognosis and possible treatment targets for concussion.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
Research has demonstrated that boosting the immune system could offer a novel treatment modality for Alzheimer’s disease.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.
According to a recent study, an anti-inflammatory drug given to patients in the early stages of a stroke could reduce harmful inflammation.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
Researchers from Japan have revealed a new neural pathway that links stress with organ dysfunction.
This article evaluates the potential role of vascular dysfunction and chronic inflammation in both acute- and chronic-phase traumatic brain injury, and also features studies investigating biomarkers associated with poorer injury outcome.